Cutera® Celebrates One Year of Revolutionizing the Acne Market with AviClear® During Acne Awareness Month
01 Junho 2023 - 9:30AM
Business Wire
The energy-based device has been used to treat
thousands of acne patients across North America.
CUTERA, INC. (Nasdaq: CUTR) a global leader in aesthetic and
dermatology solutions, today celebrates the start of Acne Awareness
Month and a year since the unveiling of AviClear, the first
FDA-cleared energy-based device for the treatment of mild,
moderate, and severe acne. Engineered with all skin types in mind,
the AviClear laser selectively targets and suppresses the sebaceous
glands, eliminating acne at the source, providing a durable
solution to acne.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20230601005355/en/
(Graphic: Business Wire)
Since its launch, AviClear has made waves in the industry,
winning ten major beauty awards from top industry publications
including NewBeauty, Elle, Good Housekeeping and two wins from
Cosmopolitan. With the device’s rising popularity, thousands of
people worldwide have already been treated with AviClear while
Cutera continues to invest in research and new applications.
“Until now, the only other treatment that targeted sebaceous
glands came with significant side effects – it’s safe to say that
AviClear has revolutionized the way my practice treats acne
patients,” said Dr. Paul Jarrod Frank a board-certified
dermatologist and founder of bespoke aesthetic healthcare brand
PFRANKMD™. "Cutera’s recent 12-month data further confirms what I
have observed with my patients – AviClear is a highly effective,
non-invasive treatment option for acne that truly delivers
long-term results."
According to clinical studies, 90% of patients experienced
visible improvement in their acne six months after their third
treatment session.1 New 12-month clinical findings show this
improvement increases to 92%,2 confirming the continual improvement
and long-term efficacy of acne clearance and skin quality over
time.
“It is hard to believe it has been only one-year since the
introduction of AviClear,” said Steve Kreider, Senior Vice
President of Global Marketing at Cutera. “Over this last year, we
have installed AviClear in over 1,000 practices nationwide,
received over 4.4 billion media impressions to date, garnered tens
of thousands of followers on our social handles, and witnessed the
powerful acne journeys and success stories of many patients and
influencers. We are excited to continue positively affecting the
lives of acne sufferers in the years to come.”
To learn more about AviClear, please visit AviClear’s website,
TikTok and Instagram.
About Cutera, Inc.
Brisbane, California-based Cutera is a leading provider of
aesthetic and dermatology solutions for practitioners worldwide.
Since 1998, Cutera has been developing innovative, easy-to-use
products that harness the power of science and nature to enable
medical practitioners to offer safe and effective treatments to
their patients. For more information, call +1 415-657-5500 or
1-888-4CUTERA or visit Cutera.com.
1,2 Data on file. FDA clearance study. Cutera, Inc.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230601005355/en/
Media: EvolveMKD – Cutera@EvolveMKD.com Investor Relations: Greg
Barker, VP, Corporate FP& A – IR@Cutera.com
Cutera (NASDAQ:CUTR)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
Cutera (NASDAQ:CUTR)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024